PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F0LS7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $445,294
Award facts
- Contract value 100% obligated
- $445,294.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $445,294.29 firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 25, 2025, with completion expected by September 26, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its established capability to fulfill Defense Logistics Agency procurement requirements through open competition. The company serves as a critical vendor for federal medical procurement needs, supplying pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order is part of the DLA's broader Pharmaceutical Prime Vendor Global Program Generation V initiative, which involves multiple awards across separate regions with the intent to engage at least three different contractors, positioning AmerisourceBergen as a key supplier within this strategic approach to global military pharmaceutical support.
Quick answers
Who was awarded contract SPE2D825F0LS7?
SPE2D825F0LS7 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 25, 2025.
How much is contract SPE2D825F0LS7 worth?
The government has obligated $445,294 on SPE2D825F0LS7.
Is contract SPE2D825F0LS7 an order under another contract?
Yes. SPE2D825F0LS7 is a delivery order under SPE2DX22D0030, an indefinite delivery contract.
Was contract SPE2D825F0LS7 competed?
The extent of competition for SPE2D825F0LS7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award